Plano’s Reata Pharmaceuticals halts chronic kidney disease drug development

Indonesia Berita Berita

Plano’s Reata Pharmaceuticals halts chronic kidney disease drug development
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 dallasnews
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 71%

The decision came as the company prepares to launch sales of another drug in its pipeline for a rare neuromuscular condition.

The setback comes as Reata is preparing to launch sales of another drug, Skyclarys, which received FDA approval in March as the first disease-specific treatment for adults with the ultra-rare neuromuscular condition Friedreich’s ataxia. Huff said the company expects commercial sales to begin by mid-August after the Food and Drug Administration completes a supplemental review of a specification involving an impurity discovered in the manufacturing process.

“We’re encouraged by the significant interest from patients and health care providers to begin Skyclarys treatment,” Huff said. Chief operating and financial officer Manmeet Soni told analysts the deal with Blackstone will free up $100 million in capital for other projects. He also said a new debt funding package from Pharmakon Advisors will give the company access to $275 million and extend its cash runway through 2026. As of March 31, Reata already had about $321 million in reserves it could tap.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

dallasnews /  🏆 18. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Salarius Pharmaceuticals stock soars premarket after FDA lifts partial clinical hold on trial of treatment for rare form of cancer that starts in childhoodSalarius Pharmaceuticals stock soars premarket after FDA lifts partial clinical hold on trial of treatment for rare form of cancer that starts in childhoodSalarius Pharmaceuticals Inc.’s stock soared 33% in premarket trade Tuesday after the company said the U.S. Food and Drug Administration has lifted a partial...
Baca lebih lajut »

Martin Shkreli-founded drug company files for bankruptcyMartin Shkreli-founded drug company files for bankruptcyVyera Pharmaceuticals, which previously settled price-fixing charges that resulted in founder Martin Shkreli being banned from the pharmaceutical industry, filed for bankruptcy late Tuesday to sell its assets.
Baca lebih lajut »

Judge halts Rockland County hotel from accepting migrants from NYCJudge halts Rockland County hotel from accepting migrants from NYCArmoni Inn and Suites can’t house migrants at their hotel – at least for now – after Orangetown officials brought them to court.
Baca lebih lajut »

Australia's TechnologyOne halts trading after being hit by cyber attackAustralia's TechnologyOne halts trading after being hit by cyber attackAustralia's TechnologyOne Ltd said on Wednesday it had detected an unauthorised third-party access to its back-office systems, becoming the latest target in a series of cyber attacks that has bogged companies in the country since last year.
Baca lebih lajut »

Freeform’s ‘Good Trouble’ Halts Production Due To WGA PicketingFreeform’s ‘Good Trouble’ Halts Production Due To WGA PicketingProduction on Freeform’s Good Trouble fifth season was halted for the day as a result of WGA picketing. Deadline understands that the series was shooting on location Agua Dulce, north of Los …
Baca lebih lajut »

Judge halts Suns bid to exit bankrupt Diamond Sports network in novel dealJudge halts Suns bid to exit bankrupt Diamond Sports network in novel dealA bankruptcy judge halted the Phoenix Suns push to exit bankrupt Diamond Sports' network in favor of a broadcast TV and streaming partner.
Baca lebih lajut »



Render Time: 2025-02-27 11:37:58